Imunon Inc (IMNN) concluded trading on Wednesday at a closing price of $0.53, with 4.62 million shares of worth about $2.45 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -41.43% during that period and on July 23, 2025 the price saw a loss of about -15.80%. Currently the company’s common shares owned by public are about 20.32M shares, out of which, 17.77M shares are available for trading.
Stock saw a price change of 6.45% in past 5 days and over the past one month there was a price change of -43.04%. Year-to-date (YTD), IMNN shares are showing a performance of -57.99% which decreased to -44.73% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.37 but also hit the highest price of $3.65 during that period. The average intraday trading volume for Imunon Inc shares is 12.40 million. The stock is currently trading -21.51% below its 20-day simple moving average (SMA20), while that difference is down -48.06% for SMA50 and it goes to -43.20% lower than SMA200.
Imunon Inc (NASDAQ: IMNN) currently have 20.32M outstanding shares and institutions hold larger chunk of about 7.94% of that.
The stock has a current market capitalization of $10.67M and its 3Y-monthly beta is at 2.18. It has posted earnings per share of -$1.41 in the same period. It has Quick Ratio of 0.88 while making debt-to-equity ratio of 2.24. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for IMNN, volatility over the week remained 23.31% while standing at 13.88% over the month.
Stock’s fiscal year EPS is expected to rise by 42.44% while it is estimated to increase by 54.60% in next year. EPS is likely to grow at an annualized rate of 37.97% for next 5-years, compared to annual growth of 32.54% made by the stock over the past 5-years.
